Key result
STEMI is linked to a ~10-fold higher incidence of cardiogenic shock versus NSTE-ACS.
Why the study?
The study was conducted to compare the clinical, electrocardiographic, and biochemical characteristics of STEMI versus NSTE-ACS and to evaluate factors associated with cardiogenic shock.
Observational (n=105)
No
Absolute Event Rate: 29% vs 3%
p-value: p=<0.01
STEMI is associated with greater inflammatory and thrombotic activation and a higher risk of cardiogenic shock than NSTE-ACS, with diabetes being a significant risk factor for shock.
May warrant closer shock monitoring in STEMI; observational data leaves open causal and therapeutic implications.
Objective: To compare the clinical, electrocardiographic, and biochemical characteristics of ST-elevation myocardial infarction (STEMI) and non-ST-elevation acute coronary syndrome (NSTE-ACS) and to evaluate factors associated with cardiogenic shock (CS). Materials and Methods: In this prospective observational study, 105 consecutive patients aged 18-80 years with acute coronary syndrome, admitted to a tertiary care center (June 2024–May 2025) were classified as STEMI ( n = 42) or NSTE-ACS ( n = 63; non-ST-elevation myocardial infarction = 48, unstable angina = 15). Clinical, electrocardiogram, and laboratory data were recorded at admission. Results: The mean age was 58 ± 10.8 years, and 74% were male. STEMI was associated with a higher incidence of CS (29% vs. 3%, P < 0.01) and lower left ventricular ejection fraction (median: 42.5% vs. 47.5%, P = 0.04) compared with NSTE-ACS. STEMI patients had higher levels of D-dimer, procalcitonin, creatine kinase-myocardial band, and neutrophil counts (all P < 0.05), consistent with greater thrombotic and inflammatory activity. CS occured more frequently in patients with diabetes (79% vs. 35%, P < 0.01) and in females (50% vs. 22%, P = 0.05). Conclusions: STEMI is associated with greater inflammatory and thrombotic activation and a higher risk of CS than NSTE-ACS. Diabetes was associated with an increased occurrence of CS. These findings require confirmation in larger studies.
No takes yet. Share an insight, caveat, or question.
Mittal et al. (2026) conducted an observational in Acute coronary syndrome (n=105). STEMI vs. NSTE-ACS was evaluated on Cardiogenic shock (p=<0.01). STEMI was associated with a significantly higher incidence of cardiogenic shock compared with NSTE-ACS (29% vs. 3%, P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: